My NCBI | Sign In
RSS Settings
  • Search: Metcalfe KA[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 29

    1.

    Oophorectomy for breast cancer prevention in women with BRCA1 or BRCA2 mutations.

    Metcalfe KA.

    Womens Health (Lond Engl). 2009 Jan;5(1):63-8. Review.PMID: 19102642 [PubMed - indexed for MEDLINE]Related articles

    2.

    Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation.

    Metcalfe KA, Finch A, Poll A, Horsman D, Kim-Sing C, Scott J, Royer R, Sun P, Narod SA.

    Br J Cancer. 2009 Jan 27;100(2):421-5. Epub 2008 Dec 16.PMID: 19088722 [PubMed - indexed for MEDLINE]Related articles

    3.

    Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study.

    Metcalfe KA, Fan I, McLaughlin J, Risch HA, Rosen B, Murphy J, Bradley L, Armel S, Sun P, Narod SA.

    Gynecol Oncol. 2009 Jan;112(1):68-72. Epub 2008 Nov 20.PMID: 19019415 [PubMed - indexed for MEDLINE]Related articles

    4.

    Clinical use of cabergoline as primary and adjunctive treatment for acromegaly.

    Moyes VJ, Metcalfe KA, Drake WM.

    Eur J Endocrinol. 2008 Nov;159(5):541-5. Epub 2008 Aug 15.PMID: 18708434 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation.

    Metcalfe KA, Foulkes WD, Kim-Sing C, Ainsworth P, Rosen B, Armel S, Poll A, Eisen A, Gilchrist D, Chudley A, Ghadirian P, Maugard C, Lemire EG, Sun P, Narod SA.

    Clin Genet. 2008 May;73(5):474-9. Epub 2008 Mar 12. Review.PMID: 18341607 [PubMed - indexed for MEDLINE]Related articles

    6.

    International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.

    Metcalfe KA, Birenbaum-Carmeli D, Lubinski J, Gronwald J, Lynch H, Moller P, Ghadirian P, Foulkes WD, Klijn J, Friedman E, Kim-Sing C, Ainsworth P, Rosen B, Domchek S, Wagner T, Tung N, Manoukian S, Couch F, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group.

    Int J Cancer. 2008 May 1;122(9):2017-22.PMID: 18196574 [PubMed - indexed for MEDLINE]Related articles

    7.

    Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.

    Metcalfe KA, Lubinski J, Ghadirian P, Lynch H, Kim-Sing C, Friedman E, Foulkes WD, Domchek S, Ainsworth P, Isaacs C, Tung N, Gronwald J, Cummings S, Wagner T, Manoukian S, Møller P, Weitzel J, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group.

    J Clin Oncol. 2008 Mar 1;26(7):1093-7. Epub 2008 Jan 14.PMID: 18195327 [PubMed - indexed for MEDLINE]Related articles

    8.

    Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation.

    Metcalfe KA, Poll A, O'Connor A, Gershman S, Armel S, Finch A, Demsky R, Rosen B, Narod SA.

    Clin Genet. 2007 Sep;72(3):208-17.PMID: 17718858 [PubMed - indexed for MEDLINE]Related articles

    9.

    The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation.

    Metcalfe KA, Snyder C, Seidel J, Hanna D, Lynch HT, Narod S.

    Fam Cancer. 2005;4(2):97-103.PMID: 15951959 [PubMed - indexed for MEDLINE]Related articles

    10.

    Time to reconsider subcutaneous mastectomy for breast-cancer prevention?

    Metcalfe KA, Semple JL, Narod SA.

    Lancet Oncol. 2005 Jun;6(6):431-4. Review.PMID: 15925821 [PubMed - indexed for MEDLINE]Related articles

    11.

    Predictors of quality of life in women with a bilateral prophylactic mastectomy.

    Metcalfe KA, Esplen MJ, Goel V, Narod SA.

    Breast J. 2005 Jan-Feb;11(1):65-9.PMID: 15647082 [PubMed - indexed for MEDLINE]Related articles

    12.

    The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers.

    Metcalfe KA, Lynch HT, Ghadirian P, Tung N, Olivotto IA, Foulkes WD, Warner E, Olopade O, Eisen A, Weber B, McLennan J, Sun P, Narod SA.

    Gynecol Oncol. 2005 Jan;96(1):222-6.PMID: 15589605 [PubMed - indexed for MEDLINE]Related articles

    13.

    Prophylactic bilateral mastectomy for breast cancer prevention.

    Metcalfe KA.

    J Womens Health (Larchmt). 2004 Sep;13(7):822-9. Review.PMID: 15385076 [PubMed - indexed for MEDLINE]Related articles

    14.

    Satisfaction with breast reconstruction in women with bilateral prophylactic mastectomy: a descriptive study.

    Metcalfe KA, Semple JL, Narod SA.

    Plast Reconstr Surg. 2004 Aug;114(2):360-6.PMID: 15277800 [PubMed - indexed for MEDLINE]Related articles

    15.

    Obstructive sleep apnea presenting as pseudopheochromocytoma: a case report.

    Hoy LJ, Emery M, Wedzicha JA, Davison AG, Chew SL, Monson JP, Metcalfe KA.

    J Clin Endocrinol Metab. 2004 May;89(5):2033-8.PMID: 15126517 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Attitudes toward preventive oophorectomy among BRCA1 mutation carriers in Poland.

    Menkiszak J, Rzepka-Górska I, Górski B, Gronwald J, Byrski T, Huzarski T, Jakubowska A, Metcalfe KA, Narod SA, Lubiński J.

    Eur J Gynaecol Oncol. 2004;25(1):93-5.PMID: 15053071 [PubMed - indexed for MEDLINE]Related articles

    17.

    Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy.

    Metcalfe KA, Esplen MJ, Goel V, Narod SA.

    Psychooncology. 2004 Jan;13(1):14-25.PMID: 14745742 [PubMed - indexed for MEDLINE]Related articles

    18.

    The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growth.

    Drake WM, Carroll PV, Maher KT, Metcalfe KA, Camacho-Hübner C, Shaw NJ, Dunger DB, Cheetham TD, Savage MO, Monson JP.

    J Clin Endocrinol Metab. 2003 Apr;88(4):1658-63.PMID: 12679453 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Evaluation of the needs of spouses of female carriers of mutations in BRCA1 and BRCA2.

    Metcalfe KA, Liede A, Trinkaus M, Hanna D, Narod SA.

    Clin Genet. 2002 Dec;62(6):464-9.PMID: 12485194 [PubMed - indexed for MEDLINE]Related articles

    20.

    Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy.

    Metcalfe KA, Narod SA.

    J Natl Cancer Inst. 2002 Oct 16;94(20):1564-9.PMID: 12381709 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Prophylactic bilateral mastectomy: patterns of practice.

    Metcalfe KA, Goel V, Lickley L, Semple J, Narod SA.

    Cancer. 2002 Jul 15;95(2):236-42.PMID: 12124821 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    A survey of TWIST for mutations in craniosynostosis reveals a variable length polyglycine tract in asymptomatic individuals.

    Elanko N, Sibbring JS, Metcalfe KA, Clayton-Smith J, Donnai D, Temple IK, Wall SA, Wilkie AO.

    Hum Mutat. 2001 Dec;18(6):535-41.PMID: 11748846 [PubMed - indexed for MEDLINE]Related articles

    23.

    Concordance for type 1 diabetes in identical twins is affected by insulin genotype.

    Metcalfe KA, Hitman GA, Rowe RE, Hawa M, Huang X, Stewart T, Leslie RD.

    Diabetes Care. 2001 May;24(5):838-42.PMID: 11347740 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling.

    Metcalfe KA, Liede A, Hoodfar E, Scott A, Foulkes WD, Narod SA.

    J Med Genet. 2000 Nov;37(11):866-74.PMID: 11073541 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Intraventricular craniopharyngioma: a long-term follow-up of six cases.

    Davies MJ, King TT, Metcalfe KA, Monson JP.

    Br J Neurosurg. 1997 Dec;11(6):533-41.PMID: 11013625 [PubMed - indexed for MEDLINE]Related articles

    26.

    Meeting the needs of women living with HIV.

    Metcalfe KA, Langstaff JE, Evans SJ, Paterson HM, Reid JL.

    Public Health Nurs. 1998 Feb;15(1):30-4.PMID: 9503951 [PubMed - indexed for MEDLINE]Related articles

    27.

    An association between type 1 diabetes and the interleukin-1 receptor type 1 gene. The DiMe Study Group. Childhood Diabetes in Finland.

    Metcalfe KA, Hitman GA, Pociot F, Bergholdt R, Tuomilehto-Wolf E, Tuomilehto J, Viswanathan M, Ramachandran A, Nerup J.

    Hum Immunol. 1996 Nov;51(1):41-8.PMID: 8911996 [PubMed - indexed for MEDLINE]Related articles

    28.

    In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. DiMe (Childhood Diabetes in Finland) Study Group.

    Metcalfe KA, Hitman GA, Fennessy MJ, McCarthy MI, Tuomilehto J, Tuomilehto-Wolf E.

    Diabetologia. 1995 Oct;38(10):1223-9.PMID: 8690176 [PubMed - indexed for MEDLINE]Related articles

    29.

    Pathophysiology of transient cranial diabetes insipidus during pregnancy.

    Williams DJ, Metcalfe KA, Skingle L, Stock AI, Beedham T, Monson JP.

    Clin Endocrinol (Oxf). 1993 Jun;38(6):595-600.PMID: 8334746 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    1 free full-text article in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity